In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021

Sulbactam-durlobactam is a β-lactam-β-lactamase inhibitor combination designed to treat serious Acinetobacter baumannii-calcoaceticus complex (ABC) infections, including carbapenem-non-susceptible and multidrug-resistant (MDR) isolates. The current study characterized the in vitro activity of sulbac...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A., Hackel, Meredith A., McLeod, Sarah M., Miller, Alita A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487466/
https://www.ncbi.nlm.nih.gov/pubmed/36005804
http://dx.doi.org/10.1128/aac.00781-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487466/
https://www.ncbi.nlm.nih.gov/pubmed/36005804
http://dx.doi.org/10.1128/aac.00781-22

Ejemplares similares